Citadel Advisors
BMRA icon

Citadel Advisors’s Biomerica BMRA Stock Holding History

Citadel Advisors’s Portfolio BMRA Stock Details BMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,488
Closed -$6.75K – 12628
2025
Q1 		$6.75K Buy
+1,488
New +$7.35K ﹤0.01% 13733
2024
Q2 		– Sell
-13
Closed -$83 – 14282
2024
Q1 		$83 Buy
+13
New +$106 ﹤0.01% 14435
2023
Q3 		– Sell
-13
Closed -$136 – 14306
2023
Q2 		$136 Sell
13
-1,050
-99% -$12.4K ﹤0.01% 14209
2023
Q1 		$15.9K Buy
1,063
+613
+136% +$13.2K ﹤0.01% 13234
2022
Q4 		$12.1K Buy
+450
New +$12.9K ﹤0.01% 13528
2022
Q1 		– Sell
-7,238
Closed -$225K – 13598
2021
Q4 		$225K Buy
+7,238
New +$279K ﹤0.01% 11606
2021
Q2 		– Sell
-1,863
Closed -$81K – 13681
2021
Q1 		$81K Buy
1,863
+113
+6% +$5.79K ﹤0.01% 12625
2020
Q4 		$70K Buy
1,750
+337
+24% +$16.9K ﹤0.01% 10414
2020
Q3 		$78K Buy
+1,413
New +$91.4K ﹤0.01% 9404

Other funds holding BMRA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citadel Advisors's BMRA Position: Q2 2024 in Review

Citadel Advisors sold out of Biomerica (BMRA) in Q2 2024, closing a stake of 4,423 shares — an estimated $29.4K sold.

Citadel Advisors first reported a position in BMRA in Q1 2019 and held it in 9 quarters. The position peaked at $155K in Q4 2022. 35 funds tracked by Wall St. Rank hold BMRA as of Q2 2024.

  • Citadel Advisors reported no remaining Biomerica position as of Q2 2024 after selling out during the quarter.
  • Citadel Advisors sold 4,423 Biomerica shares in Q2 2024, an estimated $29.4K.
  • Citadel Advisors first reported a position in Biomerica in Q1 2019 and held it in 9 quarters.
  • Citadel Advisors's Biomerica position peaked at $155K in Q4 2022.
  • 35 funds tracked by Wall St. Rank held Biomerica as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.